13G Filing: Cormorant Asset Management and Trillium Therapeutics Inc. (TRIL)

Page 6 of 10

Page 6 of 10 – SEC Filing

CUSIP NO.    89620X506
Item 1.
(a)
Name of Issuer
Trillium Therapeutics, Inc.
(b)
Address of Issuer’s Principal Executive Offices
2488 Dunwin Drive
Mississauga, Ontario L5L 1J9
Canada
Item 2.
(a)
Name of Person Filing
Cormorant Global Healthcare Master Fund, LP
Cormorant Global Healthcare GP, LLC
Cormorant Asset Management, LLC
Bihua Chen
(b)
Address of Principal Business Office or, if none, Residence
200 Clarendon Street, 52nd Floor
Boston, MA 02116
(c)
Citizenship
Cormorant Global Healthcare Master Fund, LP – Cayman Islands
Cormorant Global Healthcare GP, LLC – Delaware
Cormorant Asset Management, LLC – Delaware
Bihua Chen – United States
(d)
Title of Class of Securities
Common Shares
(e)
CUSIP Number
89620X506

Follow Trillium Therapeutics Inc. (NASDAQ:TRIL)

Page 6 of 10